1 Introduction Patients with acute kidney injury (AKI) and those receiving continuous kidney replacement therapy (CKRT, formerly known as continuous renal replacement therapy, or CRRT) represent a vulnerable group with a high risk of mortality [1-3]. These patients frequently have altered drug pharmacokinetics (PK) due to both alterations in physiology from critical illness itself and from the extracorporeal drug device [4, 5].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile